An open question to IBX management, page-32

Wow.

From the perspective of a value hunter, watching and waiting patiently for an entry into IBX, this now ticks most boxes.

- The only issue appears to be a "delay" in timelines / patient signups
- Forum morale is at all time lows
- Forum thread pests whinging non stop about minor timeline blowouts who have NFI that patient enrollments are fickly beasts and should be expected by any biotech investor who has their wits about them.

Seriously you lot, if a lower than expected signup is the biggest issue you have and want to call for Bob being sacked then it's you who needs a sack around the ears. Biotech is full of these issues during trials - nay - you should be expecting MUCH WORSE. If you truly think the company is deliberately sabotaging itself in enrollments, that it isn't doing everything it can to get the ball rolling then you have screws loose - and your only concern must be your personal hard earned. This is an investment, you may have bought at the wrong time, look at yourselves for blame.

Looking like a great time to make my entry here.